Some people use glutathione for skin health, including reducing hyperpigmentation
The active ingredient semaglutide mimics GLP-1, a hormone your body releases after eating
It acts simultaneously on glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors, producing significant reductions in body weight and improvements in glycaemic control
SSRIs are generally safe with GLP-1s
Pre-filled subcutaneous Wegovy pens are intended for single use and must be discarded after taking the dose
Why It May Occur Cognitive symptoms may arise from poor sleep, mood disruption, low energy during rapid weight change, or direct effects of altered neurotransmitter signaling tied to GLP-1 activity